Research & Development



  阿嬌道︰“誰稀罕你們的金子,我就是恨你們當初用齷齪手段害我,今天,不把我陪高興了,休想要我放下舊日的恩怨。”   長平接話道︰“有什麼章程說出來!”哥哥去在线   四個家主,四個大漢朝著名的族長,背靠青山,面臨清水說著一些不著調的話,誰都不在意嘴里說了些什麼,只要這四張嘴還能發聲就好了。哥哥撸   傳說果然是靠不住的,美人兒這種稀缺資源並沒有出現在白鹿原這片荒僻之地。   “死掉的是匈奴人跟匈奴人的僕從軍鬼奴,而我恰恰是一個匈奴人。”哥哥射视频   曹襄的屁股被老虎用頭拱了一下這才發現,老虎已經不是昔日的老虎了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo